Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY – Get Free Report) was the target of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 100 shares, a decline of 50.0% from the October 31st total of 200 shares. Based on an average daily trading volume, of 700 shares, the days-to-cover ratio is currently 0.1 days.
Aspen Pharmacare Trading Up 1.7 %
Shares of APNHY stock opened at $9.33 on Thursday. The business has a 50-day simple moving average of $10.42 and a 200-day simple moving average of $11.76. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.81 and a quick ratio of 1.07. Aspen Pharmacare has a 52-week low of $9.17 and a 52-week high of $13.69.
Aspen Pharmacare Cuts Dividend
The business also recently disclosed a dividend, which was paid on Tuesday, October 8th. Stockholders of record on Friday, September 20th were issued a $0.1202 dividend. The ex-dividend date of this dividend was Friday, September 20th.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Further Reading
- Five stocks we like better than Aspen Pharmacare
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is a Low P/E Ratio and What Does it Tell Investors?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How Technical Indicators Can Help You Find Oversold StocksĀ
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.